Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Biggest Owners Are Retail Investors Who Got Richer After Stock Soared 11% Last Week
Key Insights Significant control over Shinva Medical InstrumentLtd by retail investors implies that the general public has more power to influence management and governance-related decisions The top
Xinhua Healthcare (600587): Driven by Innovation and Accelerating Old State-owned Enterprises to Revitalize New Vitality
Incident: The company released its 2023 annual report, achieving operating income of 10.012 billion yuan (+7.87%), net profit of 654 million yuan (+30.78%), and net profit of non-return to mother of 619 million yuan (+23)
Express News | The list of stocks that continue to grow after deducting non-net profit has been released
Investors Aren't Entirely Convinced By Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Earnings
With a price-to-earnings (or "P/E") ratio of 14.8x Shinva Medical Instrument Co.,Ltd. (SHSE:600587) may be sending very bullish signals at the moment, given that almost half of all companies in China
The medical device sector fluctuated and declined in the afternoon, and Xinhua Healthcare hit a halt
The medical device sector fluctuated and declined in the afternoon. Xinhua Medical hit a halt. Yangpu Medical fell by more than 10%, while Jianfan Biotech, Innotek, and Yirui Biotech had the highest declines.
Xinhua Healthcare (600587): Focus on the main business, consolidate competitiveness, optimize structure and improve quality
Incident: The company released its 2023 annual report. In 2023, it achieved total operating revenue of 10.01 billion yuan, an increase of 7.9% over the previous year; net profit to mother of 650 million yuan, an increase of 30.8% over the previous year; net profit of 620 million yuan after deducting non-return to mother.
Xinhua Healthcare (600587) 2023 Report Review: Product Structure Continues to Improve, and International Business Is Growing Rapidly
Matters: The company released its 2023 annual report, with revenue of 10.012 billion yuan (+7.87%), net profit to mother of 654 million yuan (+30.78%), net profit of 619 million yuan (+23.20) after deducting non-net profit
Xinhua Healthcare (600587) 2023 Performance Review: Profitability Continues to Improve Rapid Growth in International Business
Incident: The company announced its 2023 results. Annual revenue of 10.012 billion yuan, up 7.87% year on year, net profit to mother was 654 million yuan, up 30.78% year on year, after deducting net profit of 619 million yuan
Xinhua Healthcare (600587) Annual Report Review Report: Continued optimization of revenue structure, impairment affects profit performance, and a high percentage of dividends give back to shareholders
Xinhua Healthcare released its 2023 annual report. The company achieved revenue of 10.012 billion yuan in 2023 (+7.87% YoY); net profit to mother 654 million yuan (+30.78% YoY); net profit after deduction
Xinhua Healthcare (600587.SH) issued 2023 annual results, with net profit of 654 million yuan, an increase of 30.78% over the previous year. It plans to transfer 5 yuan for every 10 shares to increase 3 shares
Xinhua Healthcare (600587.SH) released its 2023 annual report. The company achieved an operating income of 10 during the reporting period...
Shinva Medical InstrumentLtd's (SHSE:600587) Three-year Earnings Growth Trails the Respectable Shareholder Returns
By buying an index fund, you can roughly match the market return with ease. But if you buy good businesses at attractive prices, your portfolio returns could exceed the average market return. For ex
Express News | Xinhua Medical Testing Center passed CNAS on-site review and expansion review
Shinva Medical InstrumentLtd (SHSE:600587) Could Easily Take On More Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like
Shinva Medical InstrumentLtd (SHSE:600587) May Have Issues Allocating Its Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in con
Express News | Xinhua Medical won the bid for all products in the centralized volume procurement work of the Interprovincial Alliance for Hemodialysis Medical Consumables in 22 provinces
Xinhua Healthcare (600587.SH) received a medical device registration certificate
Xinhua Medical (600587.SH) announced that the company received the “Medical Devices...” issued by the Shandong Drug Administration
Both Retail Investors Who Control a Good Portion of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Along With Institutions Must Be Dismayed After Last Week's 3.8% Decrease
Key Insights The considerable ownership by retail investors in Shinva Medical InstrumentLtd indicates that they collectively have a greater say in management and business strategy A total of 10 inve
Insufficient Growth At Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Hampers Share Price
When close to half the companies in China have price-to-earnings ratios (or "P/E's") above 35x, you may consider Shinva Medical Instrument Co.,Ltd. (SHSE:600587) as an attractive investment with its 1
Xinhua Healthcare (600587) In-depth Research Report: Established State-owned Enterprises Set Sail Again
The established state-owned enterprise equipment leader focuses on the main business and starts again. Xinhua Medical was founded in 1943 and listed on the Shanghai Stock Exchange in 2002. The actual controller of the company is the Shandong Provincial State-owned Assets Administration Commission. Currently, the company owns medical devices, pharmaceutical equipment, medical commerce,
Xinhua Medical (600587.SH) obtained two medical device registration certificates
Xinhua Medical (600587.SH) announced that the company has received two “Medical Devices...” issued by the State Drug Administration
No Data